Tom Ceska

Senior Director, Structural Biology and Cryo-EM Operations

Tom Ceska oversees the structural biology efforts at Gandeeva Therapeutics, encompassing the technical aspects of cryo-EM analysis and algorithm improvements. Tom is an experienced structural biologist with over 20 years in the pharmaceutical industry, working on drug discovery projects and in collaborations with structural biology CROs. Most recently, Tom led a crystallography and cryo-EM group at UCB at the Slough, UK research site, where he developed this capability in-house and integrated it with CADD (Computer Aided Drug Design). He spearheaded joining the Cambridge Cryo-EM consortium to gain access to high-end electron microscopes. Tom is experienced in drug discovery, both as a project leader and in project steering teams, resulting in translation of discovered molecules to the clinic. His innovation in discovering novel molecules is exemplified in three granted patents, in different modalities and for different diseases. Tom received his BSc at Carleton University in Ottawa, his PhD at Cornell University in Ithaca, NY, and conducted postdoctoral research with Dr. Richard Henderson at the MRC laboratory of Molecular Biology in Cambridge, UK. He received his MBA from the Open University (Milton Keynes).